Log in to save to my catalogue

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_020d2b8114e240a99de43d7630aba664

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges

About this item

Full title

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2023-02, Vol.12 (4), p.617

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous cellular signal transduction pathways that regulate all aspects of life and are frequently altered in disease. Once activated through phosphorylation, these MAPKs in turn phosphorylate and activate transcription factors present either in the cytoplasm or in the nucleus, leading t...

Alternative Titles

Full title

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_020d2b8114e240a99de43d7630aba664

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_020d2b8114e240a99de43d7630aba664

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells12040617